Table 3 Characteristics of patients with DLBCL
From: Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
| Â | DLBCL with sMPMTs (n=28) | DLBCL without sMPMTs (n=671) | P value |
|---|---|---|---|
Age (years) | |||
 Range, median | 49–91, 75.5 | 27–97, 70 |  |
 Age > 60 | 24 (85.7%) | 511 (76.2%) | 0.36 |
Sex (male) | 21 (75.0%) | 361 (53.8%) | 0.032 |
B-symptoms (+) | 4 (14.3%) | 174 (25.9%) | 0.19 |
ECOG-PS (≥ 2) | 2 (7.1%) | 193 (28.8%) | 0.009 |
LDH (> ULN) | 15 (53.6%) | 383 (57.1%) | 0.70 |
Ann Arbor stage (3/4) | 11 (39.3%) | 370 (55.1%) | 0.12 |
Extranodal involvement (≥ 2) | 5 (17.9%) | 185 (27.6%) | 0.39 |
NCCN-IPI (HI/H) | 15 (53.6%) | 397 (59.2%) | 0.56 |